Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MAXLINEAR, INC Director's Dealing 2021

Mar 10, 2021

31984_dirs_2021-03-10_32f1c725-636a-4dd3-a89e-e18e48329961.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MAXLINEAR INC (MXL)
CIK: 0001288469
Period of Report: 2021-03-08

Reporting Person: WALSH BRENDAN (VP, Product Line Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-08 Common Stock A 4051 Acquired 176899 Direct
2021-03-08 Common Stock F 2144 $31.62 Disposed 174755 Direct
2021-03-08 Common Stock A 1891 Acquired 176646 Direct
2021-03-08 Common Stock F 1006 $31.62 Disposed 175640 Direct
2021-03-08 Common Stock A 4627 Acquired 180267 Direct
2021-03-08 Common Stock F 2463 $31.62 Disposed 177804 Direct
2021-03-08 Common Stock A 3084 Acquired 180888 Direct
2021-03-08 Common Stock F 1641 $31.62 Disposed 179247 Direct
2021-03-08 Common Stock A 5019 Acquired 184266 Direct
2021-03-08 Common Stock F 2672 $31.62 Disposed 181594 Direct

Footnotes

F1: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2020 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Reporting Person deferred delivery of shares of Common Stock issuable under the performance-based restricted stock award for the 2020 fiscal year. On March 8, 2021, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on the New York Stock Exchange on March 8, 2021.

F2: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2020 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Reporting Person deferred delivery of shares of Common Stock issuable under the performance-based restricted stock award for the 2020 fiscal year. On March 8, 2021, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on the New York Stock Exchange on March 8, 2021.

F3: Represents shares of Common Stock issued to the Reporting Person in connection with an annual bonus award. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the bonus award amount approved and the closing price of the Company's Common Stock in trading on the New York Stock Exchange on February 26, 2021. Reporting Person deferred delivery of shares of Common Stock issuable in connection with the annual bonus award. On March 8, 2021, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on the New York Stock Exchange on March 8, 2021.